Physiologic Hyperinsulinemia Enhances Human Skeletal Muscle Perfusion by Capillary Recruitment
Physiologic Hyperinsulinemia Enhances Human Skeletal Muscle Perfusion by Capillary Recruitment Matthew Coggins 1 , Jonathan Lindner 1 , Steve Rattigan 2 , Linda Jahn 1 , Elizabeth Fasy 1 , Sanjiv Kaul 1 and Eugene Barrett 1 1 Divisions of Cardiovascular Medicine and Endocrinology and Metabolism, Dep...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 50; no. 12; pp. 2682 - 2690 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.12.2001
|
Subjects | |
Online Access | Get full text |
ISSN | 0012-1797 1939-327X |
DOI | 10.2337/diabetes.50.12.2682 |
Cover
Summary: | Physiologic Hyperinsulinemia Enhances Human Skeletal Muscle Perfusion by Capillary Recruitment
Matthew Coggins 1 ,
Jonathan Lindner 1 ,
Steve Rattigan 2 ,
Linda Jahn 1 ,
Elizabeth Fasy 1 ,
Sanjiv Kaul 1 and
Eugene Barrett 1
1 Divisions of Cardiovascular Medicine and Endocrinology and Metabolism, Department of Internal Medicine, University of Virginia
Health Sciences Center, Charlottesville, Virginia
2 Department of Biochemistry, University of Tasmania, Tasmania, Australia
Abstract
Despite intensive study, the relation between insulin’s action on blood flow and glucose metabolism remains unclear. Insulin-induced
changes in microvascular perfusion, independent from effects on total blood flow, could be an important variable contributing
to insulin’s metabolic action. We hypothesized that modest, physiologic increments in plasma insulin concentration alter microvascular
perfusion in human skeletal muscle and that these changes can be assessed using contrast-enhanced ultrasound (CEU), a validated
method for quantifying flow by measurement of microvascular blood volume (MBV) and microvascular flow velocity (MFV). In the
first protocol, 10 healthy, fasting adults received insulin (0.05 mU · kg −1 · min −1 ) via a brachial artery for 4 h under euglycemic conditions. At baseline and after insulin infusion, MBV and MFV were measured
by CEU during continuous intravenous infusion of albumin microbubbles with intermittent harmonic ultrasound imaging of the
forearm deep flexor muscles. In the second protocol, 17 healthy, fasting adults received a 4-h infusion of either insulin
(0.1 mU · kg −1 · min −1 , n = 9) or saline ( n = 8) via a brachial artery. Microvascular volume was assessed in these subjects by an alternate CEU technique using an intra-arterial
bolus injection of albumin microbubbles at baseline and after the 4-h infusion. With both protocols, muscle glucose uptake,
plasma insulin concentration, and total blood flow to the forearm were measured at each stage. In protocol 2 subjects, tissue
extraction of 1-methylxanthine (1-MX) was measured as an index of perfused capillary volume. Caffeine, which produces 1-MX
as a metabolite, was administered to these subjects before the study to raise plasma 1-MX levels. In protocol 1 subjects,
insulin increased muscle glucose uptake (180%, P < 0.05) and MBV (54%, P < 0.01) and decreased MFV (−42%, P = 0.07) in the absence of significant changes in total forearm blood flow. In protocol 2 subjects, insulin increased glucose
uptake (220%, P < 0.01) and microvascular volume (45%, P < 0.05) with an associated moderate increase in total forearm blood flow ( P < 0.05). Using forearm 1-MX extraction, we observed a trend, though not significant, toward increasing capillary volume in
the insulin-treated subjects. In conclusion, modest physiologic increments in plasma insulin concentration increased microvascular
blood volume, indicating altered microvascular perfusion consistent with a mechanism of capillary recruitment. The increases
in microvascular (capillary) volume (despite unchanged total blood flow) indicate that the relation between insulin’s vascular
and metabolic actions cannot be fully understood using measurements of bulk blood flow alone.
Footnotes
Address correspondence and reprint requests to Eugene J. Barrett, Department of Internal Medicine, MR-4 Box 5116, University
of Virginia Health Sciences Center, Charlottesville, VA 22908. E-mail: ejb8x{at}virginia.edu .
Received for publication 19 January 2001 and accepted in revised form 15 August 2001.
1-MX, 1-methylxanthine; A-V, arterial-venous; CEU, contrast-enhanced ultrasound; HPLC, high-performance liquid chromatography;
MBV, microvascular blood volume; MFV, microvascular flow velocity; PET, positron-emission tomography. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.50.12.2682 |